Short-term long chain Omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Labrousse, Virginie F ^a,b   Nadjar, Agnès ^a,b   Joffre, Corinne ^a,b   Costes, Laurence ^a,b   Aubert, Agnès ^a,b   Grégoire, Stéphane ^c   Bretillon, Lionel ^c   Layé, Sophie ^a,b  

^a NutriNeuro Bordeaux University   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; PROTEIN C FOS; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BIOACCUMULATION; BRAIN REGION; CELL STRUCTURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; HIPPOCAMPUS; MEMORY DISORDER; MOUSE; NERVE STIMULATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECOGNITION; SPATIAL MEMORY;

ANIMALS; BRAIN; CYTOKINES; DIET; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; HIPPOCAMPUS; MALE; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; NEUROGENIC INFLAMMATION;

MUS;

EID: 84861474320     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036861     Document Type: Article

References (97)

1. Lister JP, Barnes CA, (2009) Neurobiological changes in the hippocampus during normative aging. Arch Neurol 66: 829-833.
2. Cunnane SC, Plourde M, Pifferi F, Begin M, Feart C, et al. (2009) Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 48: 239-256.
3. Fotuhi M, Mohassel P, Yaffe K, (2009) Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol 5: 140-152.
4. Yurko-Mauro K, (2010) Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline. Curr Alzheimer Res 7: 190-196.
5. Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, et al. (2010) Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 6: 456-464.
6. Lynch MA, (1998) Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1 beta? Prog Neurobiol 56: 571-589.
7. Godbout JP, Johnson RW, (2004) Interleukin-6 in the aging brain. J Neuroimmunol 147: 141-144.
8. Gemma C, Bachstetter AD, Cole MJ, Fister M, Hudson C, et al. (2007) Blockade of caspase-1 increases neurogenesis in the aged hippocampus. Eur J Neurosci 26: 2795-2803.
9. Capuron L, Schroecksnadel S, Feart C, Aubert A, Higueret D, et al. (2011) Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol Psychiatry 70: 175-182.
10. Moranis A, Delpech JC, De Smedt-Peyrusse V, Aubert A, Guesnet P, et al. (2011) Long term adequate n-3 polyunsaturated fatty acid diet protects from depressive-like behavior but not from working memory disruption and brain cytokine expression in aged mice. Brain Behav Immun.
11. Gemma C, Bickford PC, (2007) Interleukin-1beta and caspase-1: players in the regulation of age-related cognitive dysfunction. Rev Neurosci 18: 137-148.
12. Landfield PW, Rose G, Sandles L, Wohlstadter TC, Lynch G, (1977) Patterns of astroglial hypertrophy and neuronal degeneration in the hippocampus of ages, memory-deficient rats. J Gerontol 32: 3-12.
13. Lindsey JD, Landfield PW, Lynch G, (1979) Early onset and topographical distribution of hypertrophied astrocytes in hippocampus of aging rats: a quantitative study. J Gerontol 34: 661-671.
14. Hartman TK, Wengenack TM, Poduslo JF, van Deursen JM, (2007) Mutant mice with small amounts of BubR1 display accelerated age-related gliosis. Neurobiol Aging 28: 921-927.
15. Gibertini M, Newton C, Friedman H, Klein TW, (1995) Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain Behav Immun 9: 113-128.
16. Pugh CR, Nguyen KT, Gonyea JL, Fleshner M, Wakins LR, et al. (1999) Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation. Behav Brain Res 106: 109-118.
17. Barrientos RM, Higgins EA, Sprunger DB, Watkins LR, Rudy JW, et al. (2002) Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus. Behav Brain Res 134: 291-298.
18. Barrientos RM, Higgins EA, Biedenkapp JC, Sprunger DB, Wright-Hardesty KJ, et al. (2006) Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol Aging 27: 723-732.
19. Sparkman NL, Buchanan JB, Heyen JR, Chen J, Beverly JL, et al. (2006) Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J Neurosci 26: 10709-10716.
20. Tancredi V, D'Arcangelo G, Grassi F, Tarroni P, Palmieri G, et al. (1992) Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci Lett 146: 176-178.
21. Li AJ, Katafuchi T, Oda S, Hori T, Oomura Y, (1997) Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res 748: 30-38.
22. Murray CA, Lynch MA, (1998) Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age-and stress-induced impairments in long-term potentiation. J Neurosci 18: 2974-2981.
23. Kadish I, Thibault O, Blalock EM, Chen KC, Gant JC, et al. (2009) Hippocampal and cognitive aging across the lifespan: a bioenergetic shift precedes and increased cholesterol trafficking parallels memory impairment. J Neurosci 29: 1805-1816.
24. Griffin R, Nally R, Nolan Y, McCartney Y, Linden J, et al. (2006) The age-related attenuation in long-term potentiation is associated with microglial activation. J Neurochem 99: 1263-1272.
25. Choi Y, Kim HS, Shin KY, Kim EM, Kim M, et al. (2007) Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharmacology 32: 2393-2404.
26. Laye S, (2010) Polyunsaturated fatty acids, neuroinflammation and well being. Prostaglandins Leukot Essent Fatty Acids 82: 295-303.
27. Calder PC, (2007) Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 77: 327-335.
28. De Smedt-Peyrusse V, Sargueil F, Moranis A, Harizi H, Mongrand S, et al. (2008) Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization. J Neurochem 105: 296-307.
29. Lafourcade M, Larrieu T, Mato S, Duffaud A, Sepers M, et al. (2011) Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat Neurosci 14: 345-350.
30. Mingam R, Moranis A, Bluthe RM, De Smedt-Peyrusse V, Kelley KW, et al. (2008) Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice. Eur J Neurosci 28: 1877-1886.
31. Barcelo-Coblijn G, Hogyes E, Kitajka K, Puskas LG, Zvara A, et al. (2003) Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc Natl Acad Sci U S A 100: 11321-11326.
32. Calon F, Lim GP, Yang F, Morihara T, Teter B, et al. (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43: 633-645.
33. Chung WL, Chen JJ, Su HM, (2008) Fish oil supplementation of control and (n-3) fatty acid-deficient male rats enhances reference and working memory performance and increases brain regional docosahexaenoic acid levels. J Nutr 138: 1165-1171.
34. Wu A, Ying Z, Gomez-Pinilla F, (2008) Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 155: 751-759.
35. Cao D, Kevala K, Kim J, Moon HS, Jun SB, et al. (2009) Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J Neurochem 111: 510-521.
36. Dyall SC, Michael GJ, Michael-Titus AT, (2010) Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats. J Neurosci Res 88: 2091-2102.
37. Kelly L, Grehan B, Chiesa AD, O'Mara SM, Downer E, et al. (2011) The polyunsaturated fatty acids, EPA and DPA exert a protective effect in the hippocampus of the aged rat. Neurobiol Aging 32: 2318 e2311-2315.
38. Schnebelen C, Gregoire S, Joffre C, Creuzot-Garcher C, Bron A, et al. (2008) Nutrition for the eye: different susceptibility of the retina and the lacrimal gland to dietary omega-6 and omega-3 polyunsaturated fatty acid incorporation. Ophthalmic Res in press.
39. Viau S, Maire MA, Pasquis B, Gregoire S, Acar N, et al. (2009) Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefes Arch Clin Exp Ophthalmol 247: 1039-1050.
40. Schnebelen C, Gregoire S, Pasquis B, Joffre C, Creuzot-Garcher CP, et al. (2009) Dietary n-3 and n-6 PUFA enhance DHA incorporation in retinal phospholipids without affecting PGE(1) and PGE (2) levels. Lipids 44: 465-470.
41. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J, (2007) Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 27: 2596-2605.
42. Labrousse VF, Costes L, Aubert A, Darnaudery M, Ferreira G, et al. (2009) Impaired interleukin-1beta and c-Fos expression in the hippocampus is associated with a spatial memory deficit in P2X(7) receptor-deficient mice. PLoS One 4: e6006.
43. Kubik S, Miyashita T, Guzowski JF, (2007) Using immediate-early genes to map hippocampal subregional functions. Learn Mem 14: 758-770.
44. Kee N, Teixeira CM, Wang AH, Frankland PW, (2007) Imaging activation of adult-generated granule cells in spatial memory. Nat Protoc 2: 3033-3044.
45. Touzani K, Marighetto A, Jaffard R, (2003) Fos imaging reveals ageing-related changes in hippocampal response to radial maze discrimination testing in mice. Eur J Neurosci 17: 628-640.
46. Porte Y, Buhot MC, Mons N, (2008) Alteration of CREB phosphorylation and spatial memory deficits in aged 129T2/Sv mice. Neurobiol Aging 29: 1533-1546.
47. Shu SY, Ju G, Fan LZ, (1988) The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 85: 169-171.
48. Gautron L, Lafon P, Chaigniau M, Tramu G, Laye S, (2002) Spatiotemporal analysis of signal transducer and activator of transcription 3 activation in rat brain astrocytes and pituitary following peripheral immune challenge. Neuroscience 112: 717-729.
49. Das UN, Rao KP, (2006) Effect of gamma-linolenic acid and prostaglandins E1 on gamma-radiation and chemical-induced genetic damage to the bone marrow cells of mice. Prostaglandins Leukot Essent Fatty Acids 74: 165-173.
50. Dere E, Huston JP, De Souza Silva MA, (2007) The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev 31: 673-704.
51. Laping NJ, Teter B, Anderson CP, Osterburg HH, O'Callaghan JP, et al. (1994) Age-related increases in glial fibrillary acidic protein do not show proportionate changes in transcription rates or DNA methylation in the cerebral cortex and hippocampus of male rats. J Neurosci Res 39: 710-717.
52. Sykova E, Mazel T, Simonova Z, (1998) Diffusion constraints and neuron-glia interaction during aging. Exp Gerontol 33: 837-851.
53. Lalancette-Hebert M, Julien C, Cordeau P, Bohacek I, Weng YC, et al. (2011) Accumulation of dietary docosahexaenoic acid in the brain attenuates acute immune response and development of postischemic neuronal damage. Stroke 42: 2903-2909.
54. Carrie I, Smirnova M, Clement M, De JD, Frances H, et al. (2002) Docosahexaenoic acid-rich phospholipid supplementation: effect on behavior, learning ability, and retinal function in control and n-3 polyunsaturated fatty acid deficient old mice. Nutr Neurosci 5: 43-52.
55. Fedorova I, Salem N Jr, (2006) Omega-3 fatty acids and rodent behavior. Prostaglandins Leukot Essent Fatty Acids 75: 271-289.
56. Luchtman DW, Meng Q, Song C, (2012) Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease. Behav Brain Res 226: 386-396.
57. Kavanagh T, Lonergan PE, Lynch MA, (2004) Eicosapentaenoic acid and gamma-linolenic acid increase hippocampal concentrations of IL-4 and IL-10 and abrogate lipopolysaccharide-induced inhibition of long-term potentiation. Prostaglandins Leukot Essent Fatty Acids 70: 391-397.
58. Moon DO, Kim KC, Jin CY, Han MH, Park C, et al. (2007) Inhibitory effects of eicosapentaenoic acid on lipopolysaccharide-induced activation in BV2 microglia. Int Immunopharmacol 7: 222-229.
59. Lu DY, Tsao YY, Leung YM, Su KP, (2010) Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for omega-3 fatty acids. Neuropsychopharmacology 35: 2238-2248.
60. Rao JS, Ertley RN, DeMar JC Jr, Rapoport SI, Bazinet RP, et al. (2007) Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol Psychiatry 12: 151-157.
61. Barham JB, Edens MB, Fonteh AN, Johnson MM, Easter L, et al. (2000) Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr 130: 1925-1931.
62. Mukherjee PK, Marcheselli VL, de Rivero Vaccari JC, Gordon WC, Jackson FE, et al. (2007) Photoreceptor outer segment phagocytosis attenuates oxidative stress-induced apoptosis with concomitant neuroprotectin D1 synthesis. Proc Natl Acad Sci U S A 104: 13158-13163.
63. Serhan CN, Chiang N, Van Dyke TE, (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349-361.
64. Spulber S, Oprica M, Bartfai T, Winblad B, Schultzberg M, (2008) Blunted neurogenesis and gliosis due to transgenic overexpression of human soluble IL-1ra in the mouse. Eur J Neurosci 27: 549-558.
65. Champeil-Potokar G, Chaumontet C, Guesnet P, Lavialle M, Denis I, (2006) Docosahexaenoic acid (22:6n-3) enrichment of membrane phospholipids increases gap junction coupling capacity in cultured astrocytes. Eur J Neurosci 24: 3084-3090.
66. Joardar A, Das S, (2007) Effect of fatty acids isolated from edible oils like mustard, linseed or coconut on astrocytes maturation. Cell Mol Neurobiol 27: 973-983.
67. Das GD, (1976) Differentiation of Bergmann glia cells in the cerebellum: a golgi study. Brain Res 110: 199-213.
68. Gadient RA, Otten U, (1995) Interleukin-6 and interleukin-6 receptor mRNA expression in rat central nervous system. Ann N Y Acad Sci 762: 403-406.
69. Campbell IL, Stalder AK, Chiang CS, Bellinger R, Heyser CJ, et al. (1997) Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol Psychiatry 2: 125-129.
70. Gadient RA, Otten UH, (1997) Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog Neurobiol 52: 379-390.
71. Guzowski JF, McNaughton BL, Barnes CA, Worley PF, (1999) Environment-specific expression of the immediate-early gene Arc in hippocampal neuronal ensembles. Nat Neurosci 2: 1120-1124.
72. Shires KL, Aggleton JP, (2008) Mapping immediate-early gene activity in the rat after place learning in a water-maze: the importance of matched control conditions. Eur J Neurosci 28: 982-996.
73. Small SA, Chawla MK, Buonocore M, Rapp PR, Barnes CA, (2004) Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging. Proc Natl Acad Sci U S A 101: 7181-7186.
74. Mingaud F, Mormede C, Etchamendy N, Mons N, Niedergang B, et al. (2008) Retinoid hyposignaling contributes to aging-related decline in hippocampal function in short-term/working memory organization and long-term declarative memory encoding in mice. J Neurosci 28: 279-291.
75. Snyder JS, Radik R, Wojtowicz JM, Cameron HA, (2009) Anatomical gradients of adult neurogenesis and activity: young neurons in the ventral dentate gyrus are activated by water maze training. Hippocampus 19: 360-370.
76. Frankland PW, Bontempi B, (2005) The organization of recent and remote memories. Nat Rev Neurosci 6: 119-130.
77. Driscoll I, Sutherland RJ, (2005) The aging hippocampus: navigating between rat and human experiments. Rev Neurosci 16: 87-121.
78. Lipp HP, Schwegler H, Driscoll P, (1984) Postnatal modification of hippocampal circuitry alters avoidance learning in adult rats. Science 225: 80-82.
79. Crusio WE, Schwegler H, Lipp HP, (1987) Radial-maze performance and structural variation of the hippocampus in mice: a correlation with mossy fibre distribution. Brain Res 425: 182-185.
80. Nanry KP, Mundy WR, Tilson HA, (1989) Colchicine-induced alterations of reference memory in rats: role of spatial versus non-spatial task components. Behav Brain Res 35: 45-53.
81. Bernasconi-Guastalla S, Wolfer DP, Lipp HP, (1994) Hippocampal mossy fibers and swimming navigation in mice: correlations with size and left-right asymmetries. Hippocampus 4: 53-63.
82. Schuster G, Cassel JC, Will B, (1997) Comparison of the behavioral and morphological effects of colchicine- or neutral fluid-induced destruction of granule cells in the dentate gyrus of the rat. Neurobiol Learn Mem 68: 86-91.
83. Arsenault D, Julien C, Tremblay C, Calon F, (2011) DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. PLoS One 6: e17397.
84. Petursdottir AL, Farr SA, Morley JE, Banks WA, Skuladottir GV, (2008) Effect of dietary n-3 polyunsaturated fatty acids on brain lipid fatty acid composition, learning ability, and memory of senescence-accelerated mouse. J Gerontol A Biol Sci Med Sci 63: 1153-1160.
85. Vinot N, Jouin M, Lhomme-Duchadeuil A, Guesnet P, Alessandri JM, et al. (2011) Omega-3 fatty acids from fish oil lower anxiety, improve cognitive functions and reduce spontaneous locomotor activity in a non-human primate. PLoS One 6: e20491.
86. Bourre JM, (2005) Dietary omega-3 Fatty acids and psychiatry: mood, behaviour, stress, depression, dementia and aging. J Nutr Health Aging 9: 31-38.
87. Tanabe Y, Hashimoto M, Sugioka K, Maruyama M, Fujii Y, et al. (2004) Improvement of spatial cognition with dietary docosahexaenoic acid is associated with an increase in Fos expression in rat CA1 hippocampus. Clin Exp Pharmacol Physiol 31: 700-703.
88. Arendash GW, Jensen MT, Salem N Jr, Hussein N, Cracchiolo J, et al. (2007) A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Neuroscience 149: 286-302.
89. Fujita S, Ikegaya Y, Nishikawa M, Nishiyama N, Matsuki N, (2001) Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A(2) inhibitor in rat hippocampal slices. Br J Pharmacol 132: 1417-1422.
90. Lynch AM, Loane DJ, Minogue AM, Clarke RM, Kilroy D, et al. (2007) Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus. Neurobiol Aging 28: 845-855.
91. Minogue AM, Lynch AM, Loane DJ, Herron CE, Lynch MA, (2007) Modulation of amyloid-beta-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid. J Neurochem 103: 914-926.
92. Fan R, Xu F, Previti ML, Davis J, Grande AM, et al. (2007) Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J Neurosci 27: 3057-3063.
93. Mesches MH, Gemma C, Veng LM, Allgeier C, Young DA, et al. (2004) Sulindac improves memory and increases NMDA receptor subunits in aged Fischer 344 rats. Neurobiol Aging 25: 315-324.
94. Boudrault C, Bazinet RP, Ma DW, (2009) Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. J Nutr Biochem 20: 1-10.
95. Crawford MA, Bazinet RP, Sinclair AJ, (2009) Fat intake and CNS functioning: ageing and disease. Ann Nutr Metab 55: 202-228.
96. Rapoport SI, (2008) Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. Prostaglandins Leukot Essent Fatty Acids 79: 153-156.
97. Rapoport SI, (2008) Arachidonic acid and the brain. J Nutr 138: 2515-2520.